Gliomas can be classified into several molecular subtypes, many of which have a well-defined profile of driver mutations, such as those in the isocitrate dehydrogenase 1 (IDH1) or 2 (IDH2) genes [2]. This evidence concerns the gene IDH1 and central nervous system cancer.